Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Influenza as a Trigger for Acute Myocardial Infarction: a Self-controlled Case Series Analysis of Linked Data From the Myocardial Ischaemia National Audit Project (MINAP) and the General Practice Research Database (GPRD)
Brief Summary: The purpose of this study is to examine the incidence of acute myocardial infarction (MI) occurring after an influenza-like illness using linked primary care and disease registry databases.


Options:
A: Arm Label: split-virion, adjuvanted H1N1 vaccine of 7.5 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose | Arm Label: split-virion, adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 30 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 5 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 10 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose | Arm Label: Placebo control; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo control | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 7.5 μg | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 5 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 10 μg | Intervention Type: BIOLOGICAL; Name: placebo control; Assigned to Arm(s): Placebo control
B: Intervention Type: BIOLOGICAL; Name: CAIV-T; Assigned to Arm(s): N/A
C: Arm Label: Influenza A (H5N1) 18-64Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo 18-64Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) >64Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo >64Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) 18-60Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo 18-60Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) >60Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo >60Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted; Assigned to Arm(s): Influenza A (H5N1) 18-60Y Group, Influenza A (H5N1) 18-64Y Group, Influenza A (H5N1) >60Y Group, Influenza A (H5N1) >64Y Group, Influenza A (H5N1) Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo 18-60Y Group, Placebo 18-64Y Group, Placebo >60Y Group, Placebo >64Y Group, Placebo Group
D: Arm Label: MI plus respiratory illness; Type: N/A; Interventions: N/A

Answer: D